BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30734320)

  • 21. A plasma microRNA signature as a biomarker for acquired aplastic anemia.
    Hosokawa K; Kajigaya S; Feng X; Desierto MJ; Fernandez Ibanez MD; Rios O; Weinstein B; Scheinberg P; Townsley DM; Young NS
    Haematologica; 2017 Jan; 102(1):69-78. PubMed ID: 27658437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
    Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
    J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
    Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T
    Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum exosomal microRNA-144-3p: a promising biomarker for monitoring Crohn's disease.
    Chen P; Huang S; Yu Q; Chao K; Wang Y; Zhou G; Zhuang X; Zeng Z; Chen M; Zhang S
    Gastroenterol Rep (Oxf); 2022; 10():goab056. PubMed ID: 35382172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating miR-122-5p as a potential novel biomarker for diagnosis of acute myocardial infarction.
    Yao XL; Lu XL; Yan CY; Wan QL; Cheng GC; Li YM
    Int J Clin Exp Pathol; 2015; 8(12):16014-9. PubMed ID: 26884877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
    J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.
    Solem CA; Loftus EV; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ
    Inflamm Bowel Dis; 2005 Aug; 11(8):707-12. PubMed ID: 16043984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of circulating miR-125b-5p predicts survival in chronic hepatitis B patients with acute-on-chronic liver failure.
    Tao YC; Wang ML; Wang M; Ma YJ; Bai L; Feng P; Chen EQ; Tang H
    Dig Liver Dis; 2019 Mar; 51(3):412-418. PubMed ID: 30274791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating microRNAs as biomarkers of adult Crohn's disease.
    Jensen MD; Andersen RF; Christensen H; Nathan T; Kjeldsen J; Madsen JS
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1038-44. PubMed ID: 26230660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.
    Herrlinger KR; Dittmann R; Weitz G; Wehkamp J; Ludwig D; Schwab M; Stange EF; Fellermann K
    Inflamm Bowel Dis; 2004 May; 10(3):229-33. PubMed ID: 15290916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.
    Tan Y; Ge G; Pan T; Wen D; Gan J
    Clin Chim Acta; 2015 Dec; 451(Pt B):232-9. PubMed ID: 26483130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRNA-146a-5p is upregulated in serum and cartilage samples of patients with osteoarthritis.
    Skrzypa M; Szala D; Gablo N; Czech J; Pajak J; Kopanska M; Trzeciak M; Gargasz K; Snela S; Zawlik I
    Pol Przegl Chir; 2019 Feb; 91(3):1-5. PubMed ID: 31243168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of microRNAs in leukocytes and serum of asbestosis patients.
    Kauschke V; Philipp-Gehlhaar M; Schneider J
    Eur J Med Res; 2023 May; 28(1):175. PubMed ID: 37189132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucosal MicroRNAs Expression Profiles before and after Exclusive Enteral Nutrition Therapy in Adult Patients with Crohn's Disease.
    Guo Z; Gong J; Li Y; Gu L; Cao L; Wang Z; Zhu W; Li J
    Nutrients; 2016 Aug; 8(8):. PubMed ID: 27556489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
    Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes.
    Starhof C; Hejl AM; Heegaard NHH; Carlsen AL; Burton M; Lilje B; Winge K
    Mov Disord; 2019 Feb; 34(2):246-254. PubMed ID: 30557454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.